#C4CT, KOLs, & Revenue Guidance:
In Gerald's blog he
#C4CT, KOLs, & Revenue Guidance:
In Gerald's blog he again referred to the KOLs (Key Opinion Leaders) in the AD industry that were impressed by the LymPro data presented at the #C4CT Conference. Even though we shareholders may have misinterpreted the data, the scientists present....did not misinterpret it. Milestone accomplished!
All the way back to when I spoke with Gerald in Las Vegas in September 2013, he told me having an accurate blood test wasn't enough to become the "industry standard." What was needed was having the right people on your team that can persuade the KOLs in the AD to switch over to LymPro from other tests being used. Gerald was confident he had the right people, and he continues to add to his impressive team of diagnostic specialists.
When LymPro data comes out in the coming weeks and months with mid 90s sens & spec numbers, and it is less invasive and less expensive than amivid (Eli Lilly's test), the pharmas doing AD clinical trials will move in droves to LymPro! The two conferences in July may not have impressed the low scientific IQ traders who speculate on AMBS, but it got to and impressed the KOLs needed for LymPro to become the industry standard. It is ironic that there is such a gap between what has really happened at the two conferences and what shareholders perceive happened. These two conferences were about deep and powerful science, not sound bites prepared for low IQ traders.
By the time LymPro completes it's testing and it proves it is by far more accurate than amivid, (sp?) LymPro will almost instantly become the lead diagnostic test for AD clinical trials. Gerald knows what he is doing. He is on track. The IQ gap causing the discrepancy between LymPro's real value and the value the market is currently giving it will soon disappear. Gerald's revenue guidance in a week or so is going to be really interesting.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...
Continue Reading
Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...
Continue Reading
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
Top 5 Most Recently Viewed Articles
Verona Pharma Achieves Record Stock Price Milestone Verona Pharma PLC (NASDAQ: VRNA) has recently reached a remarkable milestone, with its stock price soaring to an all-time high of $49.05. This achievement highlights the company’s impressive growth trajectory and resilience in the biopharmaceutical sector, particularly in addressing respiratory diseases. Impressive...
Continue Reading
Exciting Developments from the AGM of Foresight Ventures VCT PLC FORESIGHT VENTURES VCT PLC LEI: 213800R88MRC4Y3OIW86 During the recent Annual General Meeting, Foresight Ventures VCT plc showcased a remarkable turnout in terms of shareholder engagement, underscoring the company’s commitment to transparency and active participation in governance. Key Resolutions Passed...
Continue Reading
Diego Lopes Triumphs in a Thrilling TKO Victory at Noche UFC In an electrifying match, Diego Lopes made headlines by defeating Jean Silva at the Noche UFC event. Lopes, a talented 30-year-old Brazilian fighter, displayed exceptional skill and resilience, clinching a TKO victory in the second round of the Featherweight bout. A Historic Night in Mixed Martial Arts This...
Continue Reading
Cryptocurrency Market Analysis In the past year, numerous cryptocurrencies have seen a surge as investors anticipated a decrease in interest rates, prompting a return to speculative investments. Significant events, such as the approval of the first spot price exchange-traded funds (ETFs) for Bitcoin and Ether, Ripple's favorable ruling against the U.S. Securities and...
Continue Reading
Transforming Cloud Carbon Management with GreenOps In a groundbreaking initiative, OxygenIT has introduced its GreenOps platform, providing organizations with a free and comprehensive tool designed to eliminate the guesswork involved in calculating cloud carbon footprints. This innovative approach seeks to empower businesses of any size to replace unreliable manual...
Continue Reading